PMS26 COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE VS ALENDRONATE MONOTHERAPY FOR THE PREVENTION OF FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTURE

Authors :: S. Silverman
Mickaël Hiligsmann
Rick Weiss
Setareh A. Williams
Lorraine A. Fitzpatrick
Jacques Reginster
Source :: Value in Health. 22:S243
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: medicine.medical_specialty
Increased risk
Cost effectiveness
business.industry
Health Policy
Abaloparatide
Public Health, Environmental and Occupational Health
Fracture (geology)
Medicine
business
Sequential treatment
Surgery

Full Text Access

Tools